Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28
LAVAL, Quebec, Feb. 6, 2018 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX andTSX: VRX) ("Valeant") will release its fourth-quarter and full-year 2017 financial results on Wednesday, Feb. 28, 2018. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.
| Conference Call Details |
|
| Date: |
Wednesday, Feb. 28, 2018 |
| Time: |
8:00 a.m. EST |
| Webcast: |
|
| Participant Event Dial-in: |
(844) 428-3520 (North America) |
| (409) 767-8386 (International) |
|
| Participant Passcode: |
5287247 |
| Replay Dial-in: |
(855) 859-2056 (North America) |
| (404) 537-3406 (International) |
|
| Replay Passcode: |
5287247 (replay available until Apr. 28, 2018) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
| Investor Contact: |
Media Contact: |
| Arthur Shannon |
Lainie Keller |
| (514) 856-3855 |
(908) 927-0617 |
| (877) 281-6642 (toll free) |
SOURCE Valeant Pharmaceuticals International, Inc.
Share this article